title: Beta-Blockers and Calcium Channel Blockers: First Line Agents.
abstract: Beta-blockers and calcium channel blockers (CCB) are milestones in the treatment of stable coronary ischaemic disease. Their main effects are particularly suited for the management of effort-induced angina because of the reduction of oxygen demand they achieve. The clinical benefits of these drugs are highly reproducible and have been shown to improve overall clinical outcomes. Despite the availability of other, and newer antianginal drugs, treatment guidelines continue to recommend the use of beta-blockers and calcium channel blockers as first line therapies.
authors: Área del Corazón, Hospital Universitario Central de Asturias, Avenida de Roma, s/n, 33011, Oviedo, Asturias, Spain.
authors: Isaac
authors: I
authors: Pascual
authors: Área del Corazón, Hospital Universitario Central de Asturias, Avenida de Roma, s/n, 33011, Oviedo, Asturias, Spain.
authors: Cesar
authors: C
authors: Moris
authors: Área del Corazón, Hospital Universitario Central de Asturias, Avenida de Roma, s/n, 33011, Oviedo, Asturias, Spain. avanzas@secardiologia.es.
authors: Pablo
authors: http://orcid.org/0000-0002-4958-6108
authors: P
authors: Avanzas
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers
keywords: Angina; Beta blockers; Beta receptor; Calcium channel blockers; Treatment